323 related articles for article (PubMed ID: 17457930)
1. Liver transplantation for status 1: the consequences of good intentions.
McDiarmid SV; Goodrich NP; Harper AM; Merion RM
Liver Transpl; 2007 May; 13(5):699-707. PubMed ID: 17457930
[TBL] [Abstract][Full Text] [Related]
2. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
Shneider BL; Suchy FJ; Emre S
Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
[TBL] [Abstract][Full Text] [Related]
3. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival.
Humar A; Khwaja K; Glessing B; Larson E; Asolati M; Durand B; Lake J; Payne WD
Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization and survival of adult patients awaiting liver transplantation in Chile.
Zapata R; Innocenti F; Sanhueza E; Humeres R; Rios H; Suarez L; Palacios JM; Rius M; Hepp J
Transplant Proc; 2004; 36(6):1669-70. PubMed ID: 15350446
[TBL] [Abstract][Full Text] [Related]
5. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics.
Chungfat N; Dixler I; Cohran V; Buchman A; Abecassis M; Fryer J
J Am Coll Surg; 2007 Dec; 205(6):755-61. PubMed ID: 18035258
[TBL] [Abstract][Full Text] [Related]
6. Combined orthotopic heart and liver transplantation: the need for exception status listing.
Porrett PM; Desai SS; Timmins KJ; Twomey CR; Sonnad SS; Olthoff KM
Liver Transpl; 2004 Dec; 10(12):1539-44. PubMed ID: 15558654
[TBL] [Abstract][Full Text] [Related]
7. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
[TBL] [Abstract][Full Text] [Related]
8. Referral patterns and waiting times for liver transplantation in Singapore.
Lim SG; Wai CT; Da Costa M; Sutedja DS; Lee YM; Lee KH; Tan CK; Aw MM; Quak SH; Prabhakaran K; Tan KC; Isaac J
Singapore Med J; 2006 Jul; 47(7):599-603. PubMed ID: 16810432
[TBL] [Abstract][Full Text] [Related]
9. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants.
Fryer J; Pellar S; Ormond D; Koffron A; Abecassis M
Liver Transpl; 2003 Jul; 9(7):748-53. PubMed ID: 12827564
[TBL] [Abstract][Full Text] [Related]
10. Deaths on the liver transplant waiting list: an analysis of competing risks.
Kim WR; Therneau TM; Benson JT; Kremers WK; Rosen CB; Gores GJ; Dickson ER
Hepatology; 2006 Feb; 43(2):345-51. PubMed ID: 16440361
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation in New Zealand: the first four years.
Gane E; McCall J; Streat S; Gunn K; Yeong ML; Fitt S; Keenan D; Munn S
N Z Med J; 2002 Aug; 115(1159):U120. PubMed ID: 12362165
[TBL] [Abstract][Full Text] [Related]
12. The UNOS OPTN (Organ Procurement and Transplantation Network) waiting list: 1988 through November 30, 1992.
Edwards EB; Breen TJ; Guo T; Ellison MD; Daily OP
Clin Transpl; 1992; ():61-75. PubMed ID: 1306723
[TBL] [Abstract][Full Text] [Related]
13. Effect of body mass index on the survival benefit of liver transplantation.
Pelletier SJ; Schaubel DE; Wei G; Englesbe MJ; Punch JD; Wolfe RA; Port FK; Merion RM
Liver Transpl; 2007 Dec; 13(12):1678-83. PubMed ID: 18044787
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for liver transplantation waiting list mortality.
Fink MA; Berry SR; Gow PJ; Angus PW; Wang BZ; Muralidharan V; Christophi C; Jones RM
J Gastroenterol Hepatol; 2007 Jan; 22(1):119-24. PubMed ID: 17201891
[TBL] [Abstract][Full Text] [Related]
15. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
[TBL] [Abstract][Full Text] [Related]
16. Organ allocation in pediatric transplantation in France.
Loirat C; Chalem Y; Golmard JL
Pediatr Nephrol; 2001 Dec; 16(12):964-70. PubMed ID: 11793081
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
18. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
[TBL] [Abstract][Full Text] [Related]
19. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
Pelletier SJ; Fu S; Thyagarajan V; Romero-Marrero C; Batheja MJ; Punch JD; Magee JC; Lok AS; Fontana RJ; Marrero JA
Liver Transpl; 2009 Aug; 15(8):859-68. PubMed ID: 19642139
[TBL] [Abstract][Full Text] [Related]
20. Projected survival benefit as criterion for listing and organ allocation in heart transplantation.
Krakauer H; Lin MJ; Bailey RC
J Heart Lung Transplant; 2005 Jun; 24(6):680-9. PubMed ID: 15949727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
